SCHEMBL7985287

SCHEMBL7985287

CCCCn1cnc2[nH]c(-c3cc(C)c(OCc4ccccc4)c(C)c3)nc(=O)c21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.40
ADORA2B P29275 2/20 0.38
ALDH1A1 P00352 3/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
PDE4A P27815 1/20 0.36
ADORA2A P29274 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
BRD4 O60885 3/20 0.36
HDAC2 Q92769 3/20 0.36
HDAC6 Q9UBN7 2/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
NPC1 O15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985282 0.85 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1PDE4AADORA2A
SCHEMBL7988254 0.83 ADORA2B (0.50) CNOT7ADORA2BALDH1A1KMT2AMEN1
SCHEMBL7985786 0.81 CNOT7 (0.43) CNOT7ADORA2BALDH1A1KMT2AMEN1
SCHEMBL7985382 0.80 ADORA2B (0.46) CNOT7ADORA2BALDH1A1KMT2AMEN1
SCHEMBL7984970 0.79 PARN (0.43) CNOT7
SCHEMBL7974067 0.79 ADORA2B (0.46) CNOT7ADORA2BALDH1A1KMT2AMEN1
SCHEMBL7985002 0.76 ADORA2B (0.48) CNOT7ADORA2BALDH1A1KMT2AMEN1
SCHEMBL7987444 0.76 PARN (0.42) CNOT7ALDH1A1KMT2AMEN1BRD4
SCHEMBL7985073 0.76 CNOT7 (0.46) CNOT7ADORA2BALDH1A1PDE4AADORA2A
SCHEMBL7984244 0.76 CNOT7 (0.60) CNOT7ADORA2BALDH1A1KMT2AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed